Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the stock in a transaction on Monday, August 28th. The shares were sold at an average price of $49.98, for a total transaction of $4,998,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, August 30th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.51, for a total transaction of $4,951,000.00.
  • On Wednesday, August 23rd, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.00, for a total transaction of $2,450,000.00.
  • On Thursday, August 24th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.98, for a total transaction of $4,898,000.00.
  • On Tuesday, August 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.28, for a total transaction of $4,828,000.00.
  • On Friday, August 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.82, for a total transaction of $4,882,000.00.
  • On Wednesday, August 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.71, for a total transaction of $4,971,000.00.
  • On Monday, August 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.19, for a total transaction of $5,019,000.00.
  • On Wednesday, August 9th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.20, for a total transaction of $2,560,000.00.
  • On Thursday, August 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.84, for a total transaction of $5,084,000.00.
  • On Monday, August 7th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.26, for a total transaction of $2,563,000.00.

Shares of Dolby Laboratories (DLB) opened at 50.46 on Friday. The firm has a market capitalization of $5.18 billion, a PE ratio of 25.81 and a beta of 0.79. The stock has a 50 day moving average of $51.06 and a 200-day moving average of $50.84. Dolby Laboratories has a 12 month low of $44.99 and a 12 month high of $55.02.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.10. The business had revenue of $305.67 million during the quarter, compared to analyst estimates of $296.88 million. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. The firm’s revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.62 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post $1.99 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Monday, August 7th were issued a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, August 3rd. This represents a $0.56 annualized dividend and a dividend yield of 1.11%. Dolby Laboratories’s dividend payout ratio is 28.57%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.watchlistnews.com/dolby-laboratories-dlb-major-shareholder-sells-4998000-00-in-stock/1535270.html.

Several research firms have issued reports on DLB. B. Riley reaffirmed a “dlb (” rating and set a $61.50 price objective on shares of Dolby Laboratories in a report on Wednesday, August 23rd. Zacks Investment Research raised shares of Dolby Laboratories from a “sell” rating to a “hold” rating in a report on Tuesday, July 4th. Finally, BidaskClub downgraded shares of Dolby Laboratories from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $54.38.

Several large investors have recently made changes to their positions in the stock. Watermark Asset Management Inc. purchased a new stake in shares of Dolby Laboratories during the first quarter valued at about $114,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Dolby Laboratories by 9.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,331 shares of the electronics maker’s stock valued at $114,000 after buying an additional 209 shares in the last quarter. US Bancorp DE raised its stake in shares of Dolby Laboratories by 2.6% in the second quarter. US Bancorp DE now owns 3,029 shares of the electronics maker’s stock valued at $149,000 after buying an additional 78 shares in the last quarter. James Investment Research Inc. purchased a new stake in shares of Dolby Laboratories during the first quarter valued at about $155,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Dolby Laboratories by 25.5% in the second quarter. The Manufacturers Life Insurance Company now owns 3,564 shares of the electronics maker’s stock valued at $174,000 after buying an additional 725 shares in the last quarter. Institutional investors and hedge funds own 51.87% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.